Anat Nevo-Shor

PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection

Ohad Etzion, Saeed Hamid, Yoav Lurie et al. · Journal of Hepatology · 2019 · 53 citations

Viral Persistence, Hepatology, Viral Hepatitis +10

Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial

Ohad Etzion, Saeed Hamid, Yoav Lurie et al. · Hepatology · 2023 · 40 citations · Full text

Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism

Anat Nevo-Shor, Slava Kogan, Ben‐Zion Joshua et al. · Bone · 2016 · 27 citations

Serum Calcium, Urology, Parathyroid Hormone +6

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study

Ohad Etzion, Harel Dahari, David Yardeni et al. · Scientific Reports · 2020 · 25 citations · Full text

Glucagon-like peptide-1 receptor agonists significantly affect the quality of bowel preparation for colonoscopy

Naim Abu‐Freha, Avraham Yitzhak, Haim Shirin et al. · Endoscopy · 2024 · 17 citations